NCT01167413 Frequency of Axial Spondyloarthropathy Among Patients Suffering From Fibromyalgia Status UNKNOWN Phase N/A
NCT01163916 Study to Characterize Demographics, Compliance, Tolerability and Safety in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Prescribed Adalimumab (Humira®) as Part of Routine Clinical Care Status COMPLETED Phase N/A
NCT01148901 Effectiveness and Safety of Early Treatment With Infliximab for Hip Arthritis Associated With Ankylosing Spondylitis (AS) (P06451) Status WITHDRAWN Phase PHASE4
NCT01118728 Extension Study for Long Term Evaluation of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis Status TERMINATED Phase PHASE2
NCT01114880 Efficacy and Safety of Adalimumab in Adult Chinese Subjects With Active Ankylosing Spondylitis Status COMPLETED Phase PHASE3
NCT01109940 Safety and Tolerability of AIN457 in Adults (18-65 Years) With Moderate to Severe Ankylosing Spondylitis Status COMPLETED Phase PHASE2
NCT01104987 Treatment With Alendronate in Patients With Ankylosing Spondylitis (AS) Status COMPLETED Phase N/A
NCT01091675 Assessment of the Response to Etoricoxib in Patients With Ankylosing Spondylitis and Inadequate Response to ≥2 NSAIDs Status COMPLETED Phase PHASE3
NCT01083693 Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS) After Unsustainable Response to Biologicals and Disease Modifying Antirheumatic Drugs Status COMPLETED Phase N/A
NCT01081717 Golimumab Safety and Surveillance Program Using the Ingenix NHI Database Status COMPLETED Phase N/A
NCT01079182 Basic Documentation of Adalimumab (Humira) in Patients With Ankylosing Spondylitis (AS) Status COMPLETED Phase N/A
NCT01078558 A Belgian Registry of HUMIRA® (Adalimumab) in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis ( ProAct ) Status COMPLETED Phase N/A
NCT01077843 Post-authorization Safety Study of Etoricoxib and Other Anti-inflammatory Therapies in European Patients With Ankylosing Spondylitis (MK-0663-163) Status COMPLETED Phase N/A
NCT01061723 Dose Ranging Study to Evaluate the Efficacy and Safety of SAR153191 (REGN88) in Patients With Ankylosing Spondylitis Status COMPLETED Phase PHASE2
NCT01060098 T Cells and TNF (Tumor Necrosis Factor): The Impact of TNF Blockade Status COMPLETED Phase N/A
NCT01038011 Efficacy and Safety of Risedronate (Actonel), a Third Generation Bisphosphonate in Patients With Ankylosing Spondylitis: a Phase 2 Pilot Study Status COMPLETED Phase PHASE2
NCT00953979 Efficacy and Safety of Kunxian Capsule in Treatment Patients With Early Ankylosing Spondylitis Status COMPLETED Phase PHASE4
NCT00944658 Spondylitis Trial of Apremilast for Better Rheumatic Therapy Status COMPLETED Phase PHASE2
NCT00913302 Effects of Cardiovascular Training in Individuals With Ankylosing Spondylitis Status COMPLETED Phase NA